EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High‐Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale

Elena Maccaroni iD, Rebecca Chiariotti, Riccardo Giampieri, Francesca Bianchi, Cristiana Brugiati, Laura Belvederesi, Elisa Ambrosini, Natalia Chiodi, Emma Nicol Serritelli, Francesca Morgese, Veronica Agostinelli, Giulia Mentrasti und 12 weitere

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/7754087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 09.03.2026. Verfasst von Elena Maccaroni und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy. Hauptthemen laut MEDLINE: Genetic Counseling, Colorectal Neoplasms, Hereditary Nonpolyposis, Breast Neoplasms, Ovarian Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Validated tools assessing oncological genetic counseling (OGC) quality are lacking.

Methods

We assessed OCG effectiveness using italian‐translated version of the Genomics Outcome Scale (GOS) questionnaire. Clinical variables were collected and their association with different answers was assessed by Fisher′s exact test or Chi‐square test for either dichotomous or other categorical variables, respectively, with level of statistical significance p = 0.05.

Results

Between November 2024 and February 2025, 209 subjects who received the complete OGC program at Our Center responded to the questionnaire; median age was 56 years (25–81). Most (76%) had breast cancer, 72% received a negative test, 15% positive test, and 13% noninformative test with variant of unknown significance (VUS). Most patients answered affirmatively to Question 1, focused on OGC understanding: age ( p = 0.0181) and education ( p = 0.0028) yielded different answers. Question 2, assessing relatives risk understanding, was answered completely/partially affirmative by 94% of subjects: test result (negative noninformative vs. positive vs. VUS) was associated ( p = 0.0175) with different answers. To Question 3, related to concern, 65% confirmed their worry: education ( p = 0.0392) and cancer type ( p = 0.0128) yielded different answers. In Question 4, focused on surveillance understanding, 77% declared full or partial awareness, regardless of examined factors. In Question 5, enquiring decisional ability for themselves or family members, 72% stated they were completely/partially able to make decisions. Education ( p = 0.0287) and genetic test result ( p = 0.0090) yielded different answers. In Question 6, reflecting future planning, 69% responded completely/almost completely affirmatively, 17% were uncertain, and 14% responded partially/completely negatively, regardless of examined clinical factors.

Conclusions

GOS questionnaire confirms that OGC is useful and effective to inform patients about their condition, surveillance, and prevention. Higher levels of empowerment were seen in younger patients and those with higher education.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic CounselingColorectal Neoplasms, Hereditary NonpolyposisBreast NeoplasmsOvarian NeoplasmsHereditary Breast and Ovarian Cancer SyndromeHumansFemaleMiddle AgedAdultAgedSurveys and QuestionnairesGenetic TestingAged, 80 and overGenomicsGenetic Predisposition to Disease

Stichwörter der Autor:innen

Genomics Outcome scaleLynch syndromegenetic testhereditary breast and ovarian cancershereditary cancersoncological genetic counseling

Autor:innen und Institutionen

  • Department of Oncology, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
  • Department of Oncology, Università Politecnica delle Marche, Ancona, Italy, univpm.it.
  • Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy, univpm.it.
  • Medical Oncology Unit, AST1, Pesaro, Italy.
  • Medical Oncology Unit, Ospedale A. Murri, Fermo, Italy.
  • Medical Oncology Unit, Ospedali Santa Maria Della Pietà e Bartolomeo Eustachio-AST di Macerata, Camerino, San Severino Marche, Italy.

ORCID-Profile: Elena Maccaroni

Zitieren

APA

Maccaroni, E., Chiariotti, R., Giampieri, R., Bianchi, F., Brugiati, C., Belvederesi, L., Ambrosini, E., Chiodi, N., Serritelli, E. N., Morgese, F., Agostinelli, V., Mentrasti, G., Copparoni, C., Magnarini, A., De Filippis, C., Burattini, E., Bracci, R., Chiari, R., Del Prete, M., …, & Berardi, R. (2026). Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High‐Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale. Human Mutation, 2026(1). https://doi.org/10.1155/humu/7754087

Vancouver

Maccaroni E, Chiariotti R, Giampieri R, Bianchi F, Brugiati C, Belvederesi L, et al. Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High‐Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale. Human Mutation. 2026;2026(1). doi:10.1155/humu/7754087

BibTeX
@article{Maccaroni2026,
  author = {Maccaroni, Elena and Chiariotti, Rebecca and Giampieri, Riccardo and Bianchi, Francesca and Brugiati, Cristiana and Belvederesi, Laura and Ambrosini, Elisa and Chiodi, Natalia and Serritelli, Emma Nicol and Morgese, Francesca and Agostinelli, Veronica and Mentrasti, Giulia and Copparoni, Cecilia and Magnarini, Alice and De Filippis, Chiara and Burattini, Elena and Bracci, Raffaella and Chiari, Rita and Del Prete, Michela and Bisonni, Renato and Faloppi, Luca and Battelli, Nicola and Silva, Rosa Rita and Berardi, Rossana},
  title = {Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High‐Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/7754087}
}
Kostenlos starten →